Kairos Pharma Ltd. (KAPA)
0.72
-0.09
(-11.11%)
USD |
NYAM |
Dec 12, 16:00
0.79
+0.07
(+9.72%)
After-Hours: 20:00
Kairos Pharma Total Liabilities (Quarterly): 0.402M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Protalix Biotherapeutics, Inc. | 29.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.066M |
| Shareholders Equity (Quarterly) | 7.664M |
| Current Ratio | 16.56 |
| Net Debt Paydown Yield | 0.64% |